A Framework for Advancing Mechanistic Neurobehavioral Biomarkers in Psychiatry

推进精神病学机制性神经行为生物标志物研究的框架

阅读:3

Abstract

Neuropsychiatry has yet to surmount the fundamental challenge of mapping behavioral pathology to its underlying neural pathology. This gap limits the development of treatments for specific circuit pathologies, despite the great potential of neuroimaging measures. We show that the field may be moving toward refining limited statistical frameworks, while clinically translatable solutions could emerge with broader considerations. We posit that the failure to operate within a formalism that defines falsifiable parameters might have hindered progress. Here, we propose a provisional formalism with the intention of bringing elements into focus that seem necessary to advance the development of precision treatments in psychiatry. Specifically, we propose that this formalism should consider 3 defining axes: 1) type of mechanism, 2) severity of mechanism, and 3) time. These 3 axes define a 3-dimensional dynamic mechanism complexity space (MCS). In turn, we posit that at any point in this MCS, there are embedded neurobehavioral subspaces or geometries for neural-to-symptom variation, which themselves are multidimensional and dynamic. This formalism provides for the mapping of the MCS to a neurobehavioral subspace. Furthermore, we articulate how this formalism accommodates integration of spectra from genetics and systems biology (transcriptomics, epigenomics, etc.) to neural mechanisms, symptom variance, and ultimately taxa of mental illness (i.e., categories). Finally, we argue that this formalism creates an opportunity to evaluate different types of treatment development that map onto dynamically evolving mechanisms of illness that are likely a hallmark feature of neuropsychiatric illness.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。